Arab Press

بالشعب و للشعب
Sunday, Apr 26, 2026

Facebook paid ads are promoting a horse drug as a COVID cure

Facebook paid ads are promoting a horse drug as a COVID cure

Paid adverts, Marketplace listings and closed groups are promoting a discredited drug. The experts say it's not a cure, and people shouldn't use it to treat the virus.

A drug commonly used to treat parasites in horses, cattle, and dogs is being promoted as a COVID-19 cure in Facebook groups and paid adverts hosted on the company's platforms, Euronews Next has found.

Information from Facebook's open "Ad Library" shows the company is currently showing users paid adverts that promote Ivermectin as a treatment for COVID-19. While Ivermectin is used to treat some conditions in humans, the drug is not licensed or approved for use in treating COVID-19.

Euronews Next also found evidence of closed Facebook groups that offer advice on sourcing and using Ivermectin, as well as examples of it being offered for sale on Facebook Marketplace and within Facebook groups.

Many of the active adverts on Facebook were purchased this week, days after public health officials in the US state of Mississippi announced that "at least 70 per cent" of recent calls to poison control helplines in the state were "related to ingestion of livestock or animal formulations of Ivermectin purchased at livestock supply centres".

Facebook's disinformation marketplace


A search of Facebook's Ad Library carried out by Euronews Next on August 24 revealed an array of paid adverts explicitly pushing Ivermectin as a COVID-19 treatment for humans to users in the United States.

One advert from a pharmacy chain in Louisiana claimed it was "fully stocked with Ivermectin," while another for a clinic in Arkansas said "YES I use Ivermectin to treat COVID," and claimed the drug produced positive results.

Paid adverts on Facebook make claims about Ivermectin that go against medical advice from regulators worldwide


Another advert promoting a wellness blogger's page suggested she used Ivermectin along with eating kale and blueberries to boost her immunity to disease.

The European Medicines Agency (EMA), the US Food and Drug Administration (FDA), and the World Health Organization (WHO) all say Ivermectin should only be used to treat COVID under direct medical supervision as part of controlled clinical trials.

Facebook's policy governing misleading claims in adverts on its platforms says "ads must not contain deceptive, false or misleading claims, such as those relating to the effectiveness or characteristics of a product or service".

Euronews Next asked Facebook to comment on the adverts, but the company had not responded at the time of publication.

‘Use at your own risk’


Facebook Marketplace, a service that allows users to buy and sell products, also played host to listings for Ivermectin.

One Florida-based seller offering six tubes of apple-flavoured Ivermectin paste meant for horses told Euronews Next "a lot of people" were using the drug to treat COVID-19, but claimed he "wasn't selling it for that".

"After you get it you can use it however you like," he added.

A search for "Ivermectin" in the southeastern United States brought up a number of results


When asked what the right dosage of the paste would be for a human, he said "You definitely have to use the correct dose," adding, "I have a chart but use at your own risk."

A spokesperson for the Medicines and Healthcare products Regulatory Agency (MHRA), the UK body which regulates medical products, told Euronews Next that medications must be put through robust clinical trials before being authorised for specific uses.

"A marketing authorisation for an ivermectin-containing medicine would only be issued based on robust data demonstrating a positive risk benefit for the quality, safety and efficacy of the product," they said.

No such authorisation has been obtained in the UK, US or EU.

‘For animal use only’


A search on Facebook also revealed a large number of groups devoted to Ivermectin. The largest closed group had over 25,000 members at the time Euronews Next joined.

Inside these groups were a large number of posts asking for advice on obtaining and using Ivermectin.

Some posts asked for advice on using Ivermectin. Medical regulators Euronews Next spoke to say medical advice should be sought from your doctor


Some users wanted to know how much of the drug to take, posting photos of bottles of Ivermectin clearly marked as "for animal use only".

Other posts found by Euronews Next discussed side effects of taking the drug. One user in a South Africa-based group said she was "dizzy...can't walk straight".

"My vision gets weird if I take Ivermectin a [sic] few consecutive days," said another.

The same group contained a large number of posts offering Ivermectin for sale, some of which implicitly acknowledged the drug's intended use of treating cattle and horses for parasitic worms.

One group featured a large number of posts advertising Ivermectin for sale via WhatsApp


"Moo moo juice 500ml available," one advert read, offering a price and contact number for the seller.

In February, Ivermectin maker Merck said its own analysis of studies looking at the use of the drug to treat COVID-19 found that there was "no scientific basis for a potential therapeutic effect against COVID-19 from pre-clinical studies; No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease, and; A concerning lack of safety data in the majority of studies."

Anti-vaccine sentiment


Many of the groups Euronews Next joined contained anti-vaccine posts that spread disinformation about the COVID-19 vaccines.

The administrator of the largest Ivermectin group Euronews Next found claimed that "a question about self-medication as a layman, an anti-vaxxer post or a comment will be banned immediately". However, there was extensive evidence of anti-vaccine sentiment within the closed group.

Many users Euronews Next found in Ivermectin groups were hostile to COVID-19 vaccines


"No thank you, I won't be the government's guinea pig," responded one group member to a post encouraging users to get vaccinated. "There's an evil, hidden agenda at work," said another.

The most lurid posts in the group included wild and unsubstantiated claims that the COVID vaccines were poisonous and contained "nanobots," as well as the false claim that people who received the jabs would die within two years.

Euronews Next contacted Facebook to raise concerns about the Marketplace listings and the groups spreading disinformation about COVID vaccines and Ivermectin.

The social network did not comment at the time of publication.

Facebook under pressure


In recent weeks Facebook has come under increased pressure to tackle COVID-related disinformation on its platforms.

In July, US President Joe Biden criticised social media companies, saying the disinformation appearing on some platforms was "killing people".

Biden later clarified his comments, saying they referred to disinformation being spread by twelve specific Facebook accounts. The company has since said it has deleted the accounts.

Last year Facebook launched its COVID-19 Information Centre, which directs users to localised information about the pandemic in their country. The prompts appear next to posts about COVID or related topics, like the vaccine.

In a post responding to Biden's criticism, Facebook claimed that "more than 2 billion people have viewed authoritative information about COVID-19 and vaccines on Facebook," and that over 3 million Americans had used the company's vaccine checker to find their nearest place to get a jab.

But while the prompts Facebook displays can offer warnings about COVID disinformation to users, they do not prevent people from clicking links or sharing content.

"Every time I see that stupid Facebook fact check COVID warning I am compelled to read the article in depth," one user wrote under an article marked with a prompt that read "some unapproved COVID-19 treatments may cause serious harm".

Newsletter

Related Articles

Arab Press
0:00
0:00
Close
News Roundup
Strategic Saudi-Bahrain Causeway Closed Amid Security Concerns as Trump Deadline Approaches
Saudi Arabia Keeps Red Sea Oil Exports Flowing Despite Regional Tensions
Pipeline Attack Cuts Significant Share of Saudi Arabia’s Oil Export Capacity
Saudi Business Leader Abudawood Appointed Chairman of Merit Incentives Group
TotalEnergies Confirms Damage at Saudi Refinery Following Security Incident
Saudi Arabia Launches Early Construction Phase for King Salman Stadium Project
Saudi Shift Away from Longstanding Dollar Oil Framework Gains Attention Amid Iran Conflict
Türkiye and Saudi Arabia Resolve Long-Running Transit Visa Dispute
Saudi Oil Capacity and Pipeline Flows Reduced as Supply Risks Intensify
TotalEnergies Reports Damage to Saudi SATORP Refinery Following Security Incidents
Gulf States Assess Prospects of U.S.-Iran Truce as Regional Stability Efforts Intensify
South Korea Resumes Honey Exports to Saudi Arabia Following Sanitary Approval
Saudi Arabia Carries Out Sentences in Eastern Province Following Security Convictions
Saudi Sovereign Wealth Fund Backs King Street’s Regional Credit Strategy
Saudi Arabia Secures World Cup Return as Egypt Celebrates Landmark Qualification
Iran and Saudi Arabia Intensify Diplomatic Engagement Amid Regional Tensions
Russia and Saudi Arabia Open Visa-Free Travel Corridor for Citizens
Saudi Oil Output Capacity Reduced by 600,000 Barrels Per Day Amid Regional Conflict
Saudi Arabia Suspends Operations at Select Energy Sites as Precautionary Measure
Saudi Arabia Halts Operations at Multiple Energy Facilities Amid Heightened Tensions
Global Markets Jolt as Iran Signals Ceasefire Breakdown and Rising Regional Tensions
King Street Aligns with Saudi Sovereign Wealth Fund to Expand Alternative Investments in Middle East
Attack on Saudi Arabia’s Jubail Petrochemical Hub Raises Global Supply Concerns
Debate Emerges Over Saudi Strategic Decisions as Gulf Cooperation Council Dynamics Come Into Focus
Saudi Arabia Expands Full Workforce Localisation to 69 Professions in Major Labour Reform
Emerging Alliance of Pakistan, Turkey, Egypt and Saudi Arabia Signals New Regional Power Dynamic Amid Iran Conflict
Iran Linked to Strikes Across Gulf States Following Refinery Attack Escalation
Saudi Arabia Voices Concern Over Fragile US–Iran Ceasefire Stability
Starmer Warns Sustained Effort Needed to Ensure US–Iran Ceasefire Holds
Saudi Arabia’s Key East-West Oil Pipeline Targeted Following Ceasefire Announcement
Iran Targets Saudi Arabia’s East-West Oil Pipeline in Escalating Regional Tensions
Trump Warns of Civilizational Stakes as Iran Halts Negotiations
Saudi Companies Expand Remote Work Measures Ahead of Iran-Related Security Concerns
Iran Warns of Strikes on Saudi Energy Infrastructure if US Targets Its Facilities
Iran Urges Civilians to Form Human Shields Around Nuclear Sites as Diplomatic Deadline Approaches
Saudi Arabia Raises Oil Prices to Record Premiums Amid Supply Pressures Linked to Iran Conflict
Key Saudi-Bahrain Causeway Closed Amid Heightened Security Concerns Linked to Iran
Formula One Calendar Gap Explained as Fans Await Next Grand Prix
Growing Strain on the Petrodollar System Comes Into Focus Amid Iran Conflict
Reported Strike on Saudi Arabia’s Jubail Complex Raises Global Energy Supply Concerns
FedEx Introduces New Digital Tool to Streamline Imports into Saudi Arabia
Iran Claims Strike on Saudi Arabia’s Jubail Petrochemical Complex Amid Rising Regional Tensions
Taiwan to Source Oil Shipments from Saudi Arabia’s Red Sea Ports
Saudi Arabia Evacuates Riyadh Financial District as Precaution Amid Regional Tensions
Saudi Arabia Balances Ambitious Economic Vision Amid Regional Tensions and Financial Pressures
Budget Saudi Arabia Reports Strong Full-Year 2025 Financial Performance
Saudi Arabia Expands Investment in Capcom With Stake Reaching Six Percent
Saudi Arabia Assesses Significant Economic Impact From Regional Conflict Involving Iran
US Beef Secures Expanded Market Access in Saudi Arabia
×